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Abstract: The aryl hydrocarbon receptor (AHR) is an environmental sensing molecule which
impacts diverse cellular functions such as immune responses, cell growth, respiratory function,
and hematopoietic stem cell differentiation. It is widely accepted that the degradation of AHR by 26S
proteasome occurs after ligand activation. Recently, we discovered that HeLa cells can modulate the
AHR levels via protein degradation without exogenous treatment of a ligand, and this degradation
is particularly apparent when the p23 content is down-regulated. Inhibition of autophagy by a
chemical agent (such as chloroquine, bafilomycin A1, or 3-methyladenine) increases the AHR protein
levels in HeLa cells whereas activation of autophagy by short-term nutrition deprivation reduces its
levels. Treatment of chloroquine retards the degradation of AHR and triggers physical interaction
between AHR and LC3B. Knockdown of LC3B suppresses the chloroquine-mediated increase of
AHR. Down-regulation of p23 promotes AHR degradation via autophagy with no change of the
autophagy-related gene expression. Although most data in this study were derived from HeLa cells,
human lung (A549), liver (Hep3B), and breast (T-47D and MDA-MB-468) cells also exhibit AHR
levels sensitive to chloroquine treatment and AHR–p62/LC3 interactions. Here we provide evidence
supporting that AHR undergoes the p62/LC3-mediated selective autophagy in HeLa cells.
Keywords: AHR; macroautophagy; p23; LC3; p62
1. Introduction
The aryl hydrocarbon receptor (AHR) is originally recognized as a transcription factor in response
to environmental toxicants such as dioxins and polycyclic aromatic hydrocarbons [1]. Since then,
more roles of AHR such as its involvement in organ development [2], immune responses [3,4], nervous
system homeostasis [5], and carcinogenesis [6,7] have been reported. Not surprisingly, AHR has
become a promising target for the treatment of diseases such as autoimmune diseases, inflammation,
and cancers. However, the AHR function is often ligand-, cell context-, and tissue-specific, confounding
the feasibility of targeting AHR for rational drug design. Understanding the basic biology of AHR
would provide much-needed information for effective modulation of the AHR function.
AHR resides in the cytoplasm as a complex with HSP90, XAP2, and p23. The p23 co-chaperone
is in a variety of HSP90 client protein complexes [8–11]. It has been reported that p23 stabilizes
the ATP-induced conformation of the HSP90-AHR complex [12,13]. The AHR function can also be
enhanced by p23 in vitro [12,14–16], but surprisingly this enhancement is not observed in the p23-null
mouse embryo [17], possibly due to yet unidentified compensatory mechanisms. The effect of p23 on
AHR is largely uncharacterized at present.
Autophagy is essential in maintaining cell homeostasis by delivering cytosolic cargos to lysosomes
for degradation. There are three types of autophagy: macroautophagy which involves the formation
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of autophagosome, followed by its fusion with lysosome; microautophagy which involves substrates
that are directly sequestered via lysosomal invagination; and lastly, chaperone-mediated autophagy
which involves the HSC70-mediated delivery of client proteins into lysosome via interaction with
LAMP-2A (for general review, see [18]). Although macroautophagy is generally known to deliver
bulk cargos to lysosomes in a non-selective manner, it can also be selective in delivering cargo
proteins for lysosomal degradation. Recognition of client proteins by cargo receptors (such as p62)
provides the selectivity of macroautophagy. This recognition, in most cases, is mediated through the
ubiquitination of client proteins. Different linkages of ubiquitin destine the ubiquitinated proteins
to different degradation pathways; for example, K63 ubiquitination is usually recognized by cargo
receptors to undergo lysosomal degradation whereas proteins with K48 ubiquitination are specifically
delivered to 26S proteasome for degradation [19]. After K63 ubiquitination of a client protein, LC3B-II,
a phosphatidylethanolamine-conjugated, membrane-bound form of cleaved LC3B-I [20], forms the
autophagosome with the client protein–cargo receptor complex, leading to lysosomal degradation of
the client protein [20,21].
Upon binding of a ligand, AHR translocates into the nucleus and activates gene transcription.
The liganded AHR is subsequently degraded by the ubiquitin–proteasome system to limit its
transactivation function [22]. However, how AHR is regulated in the absence of exogenous ligand
treatment remained unclear. We previously discovered that down-regulation of just half of the
p23 cellular content is sufficient in causing a lower cellular content of AHR in various cancer and
untransformed cell types in vitro [15,16,23]. AHR is degraded significantly faster in the p23 knockdown
Hepa1c1c7 cells; however, inhibition of proteasome activity by MG132 cannot restore the AHR protein
levels, suggesting that AHR is not degraded by the 26S proteasome when p23 is down-regulated [15].
Treatment of MG132, surprisingly, decreases the AHR protein levels in both wild type and p23
knockdown Hepa1c1c7 cells, suggesting that mechanisms in degrading the unliganded AHR protein
could be enhanced by proteasomal inhibition. It has been reported that crosstalk occurs between
the ubiquitin–proteasome system (UPS) and autophagy [24,25]. Blockade of UPS leads to protein
aggregation, which in turn triggers the autophagy-mediated protein degradation [26]. In addition,
reduced amino acids in cells as a consequence of MG132 treatment can activate autophagy [27]. Thus,
we explored whether the autophagy-lysosomal system is responsible for the degradation of AHR
without exogenous ligand treatment. Here we provide evidence to support that the basal AHR
protein levels in HeLa cells are controlled by selective autophagy. Knockdown of p23 reduces AHR
protein levels by promoting the K63-linked ubiquitination of AHR, followed by the p62/LC3-mediated
AHR degradation.
2. Results
2.1. Autophagy Activity in Wild Type and p23 Stable Knockdown HeLa Cells Governs the Levels of AHR
We previously observed that suppression of the AHR levels after down-regulation of p23 in
Hepa1c1c7 mouse hepatoma cells was caused by increased AHR degradation, which could not be
reversed by the treatment of a proteasome inhibitor MG132 [15]. In this study, we observed that
MG132 similarly reduced the AHR content in wild type and p23 knockdown (human cervical) HeLa
cells in a statistically significant manner (Figure 1A). We then explored whether this AHR degradation
could be mediated through autophagy-mediated lysosomal degradation. We treated the HeLa cells
with an autophagy inhibitor CQ at 20 or 40 µM for six hours. We observed that the AHR protein
levels in both wild type and p23 stable knockdown HeLa cells were increased in the presence of
40 µM CQ (Figure 1B,C). The cellular AHR protein levels in p23 stable knockdown HeLa cells was
about 54% when compared to that of wild type HeLa cells (Figure 1C, “WT” versus “NT”). However,
the AHR levels in p23 stable knockdown cells became even higher than the levels in wild type cells
after treatment of 40 µM CQ for six hours, suggesting that mechanism of the p23-mediated AHR
degradation can be reversed by CQ. Next, we performed the cycloheximide experiment to examine
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whether degradation of AHR is mediated through autophagy. Basically, when protein synthesis in
HeLa cells is blocked by cycloheximide, any reduction of the AHR content is the consequence of
protein degradation. If this degradation is mediated through autophagy, CQ should, in principle,
reverse the AHR reduction in the presence of cycloheximide. Indeed, we observed that degradation of
the AHR protein in p23 stable knockdown and wild type HeLa cells was inhibited in the presence
of CQ (Figure 1D,E, “CHX” versus “CHX+CQ”). Two other autophagy inhibitors, namely Baf A1
and 3MA, also increased the AHR protein levels in p23 stable knockdown HeLa cells (Figure 1F,G).
However, only 5 mM 3MA, but not 6 nM Baf A1, increased the AHR levels in wild type HeLa cells.
An autophagy inducer metformin decreased the AHR protein levels in p23 knockdown but not in wild
type HeLa cells at 1 mM concentration (Figure 1H). We cannot rule out the possibility that a higher
concentration of Baf A1 and metformin is necessary for eliciting changes of the AHR levels in wild type
HeLa cells. Nonetheless, these data supported that the basal AHR undergoes the autophagy-mediated
degradation in HeLa cells and this degradation is more apparent when p23 is down-regulated.
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Figure 1. Using an autophagy inhibitor or activator to reveal that the aryl hydrocarbon receptor (AHR) 
undergoes autophagy in wild type (WT) and p23 stable knockdown (p23KD) HeLa cells. (A) MG132 
(10 μM for 6 h) decreased AHR protein levels more in HeLa cells transiently transfected with p23 
shRNA (2.5 μg for 48 h) than in WT HeLa cells. EndoFectin transfection reagent (2:1) was used. The 
below images are representative of the replicate data (means ± SD, n = 4). Conditions with no MG132 
treatment were arbitrarily set as one (with no error bar) for data normalization. Multiple t-tests 
corrected with the Holm-Sidak method for multiple comparisons were performed to determine 
statistical significance. (B) WT and (C) p23KD HeLa cells were treated with 20 μM or 40 μM 
chloroquine (CQ) dissolved in water for 6 h. Western analysis results showed a higher increase of 
Figure 1. Cont.
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representative of the replicate data of one experiment (means ± SD, n = 3). Conditions with no addition 
as no treatment (NT) were arbitrarily set as one for comparison. This experiment was repeated once 
with similar results. One-way ANOVA with Sidak’s multiple comparisons test was performed to 




Figure 1. Cont. (D) WT and (E) p23KD HeLa cells were treated with 40 μg/mL of cycloheximide (CHX) 
for 6 h in the presence or absence of 40 μM CQ for 12 h (6 h pre-treatment and then co-treated with 
CHX for another 6 h). The degradation of AHR in both cell lines was inhibited by CQ. For (D,E), the 
below images are representative of the replicate data (means ± SD, n = 3). Conditions with no addition 
Figure 1. Using an autophagy inhibitor or activator to reveal that the aryl hydrocarbon receptor (AHR)
undergoes autophagy in wild type (WT) and p23 stable knockdown (p23KD) HeLa cells. (A) MG132
(10 µM for 6 h) decreased AHR protein levels more in HeLa cells tran iently transfected with p23 shRNA
(2.5 µg for 48 h) th n in WT HeLa cells. EndoFectin transfection reagent (2:1) was used. The below
images are representative of the replicate data (means± SD, n = 4). Conditions with no MG132 treatment
were arbitrarily set as one (with no error bar) for data normalization. Multiple t-tests corrected with the
Holm-Sidak method for multiple comparisons were performed to determine statistical significance.
(B) WT and (C) p23KD HeLa cells were treated with 20 µM or 40 µM chloroquine (CQ) dissolved in
water for 6 h. Western analysis results showed a higher increase of AHR in p23KD than in WT HeLa
cells after 40 µM CQ treatment. For (B,C), the below images are representative of the replicate data of
one experiment (means ± SD, n = 3). Conditions with no addition as no treatment (NT) were arbitrarily
set as one for comparison. This experiment was repeated once with similar results. One-way ANOVA
with Sidak’s multiple comparisons test was performed to determine statistical significance.
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(D) WT and (E) p23KD HeLa cells were treated with 40 µg/mL of cycloheximide (CHX) for 6 h in the
presence or absence of 40 µM CQ for 12 h (6 h pre-treatment and then co-treated with CHX for another
6 h). The degradation of AHR in both cell lines was inhibited by CQ. For (D,E), the below images are
representative of the replicate data (means ± SD, n = 3). Conditions with no addition as no treatment
(NT) were arbitrarily set as one (with no error bar) for data normalization. Multiple t-tests corrected with
the Holm-Sidak method for multiple comparisons were performed to determine statistical significance.
(F) Treatment of 6 nM Bafilomycin A1 (Baf A1) dissolved in DMSO for 3 h increased AHR protein levels
only in p23KD cells but not WT HeLa cells. (G) Treatment of 5 mM 3-methyladenine (3MA) dissolved
in DMEM for 24 h increased AHR protein levels in WT and p23KD HeLa cells. For (F,G), the below
images are representative of the replicate data (means ± SD, n = 3 for (F), n = 4 for (G)). Conditions
with DMSO treatment and no addition as no treatment (NT) of WT and p23KD were arbitrarily set as
one (with no error bar) for data normalization. Multiple t-tests corrected with the Holm-Sidak method
for multiple comparisons were performed to determine statistical significance. (H) Treatment of 1 mM
metformin (Met) for 4 h decreased AHR protein levels in p23KD HeLa cells but not in WT HeLa cells.
The above images represent the replicate data of one experiment (means ± SD, n = 3). Conditions with
no treatment (NT) were arbitrarily set as one for comparison. This experiment was repeated once
with similar results. Multiple t-tests corrected with the Holm-Sidak method for multiple comparisons
were performed to determine statistical significance. For (A–H), each Western lane contained 30 µg of
whole-cell lysate. Data in (D,F) were normalized by β-actin (as shown) whereas the rest of the data
were normalized by total protein stain.
2.2. Short-Term Nutrient Deprivation Triggers Degradation of AHR in HeLa Cells When Either p23 or HSP90
is Down-Regulated
To further investigate whether autophagy is involved in the degradation of AHR, we treated the
HeLa cells with HBSS to mimic nutrient deprivation, which is known to cause autophagy. We observed
that the AHR protein levels were reduced after 15 min of HBSS treatment and were then gradually
increased up to four hours in p23 knockdown HeLa cells (Figure 2A). In contrast, the AHR protein levels
of wild type HeLa cells were steadily increased up to four hours of HBSS treatment. Pre-treatment of
CQ hampered the reduction of AHR in p23 knockdown HeLa cells, suggesting that this decrease of
AHR protein levels is caused by autophagy (Figure 2B). We hypothesized that some compensatory
mechanism may be involved in protecting AHR from degradation under nutrition deprivation in HeLa
cells. Given that HSP90 stabilizes the cytosolic AHR complex, we examined whether HSP90 would
protect AHR from degradation caused by nutrient deprivation in HeLa cells. We down-regulated
HSP90 in HeLa cells with shRNA via lentiviral infection and then treated these HSP90 knockdown
cells with HBSS. We observed that these cells exhibited similar characteristics as the p23 knockdown
cells but not as the wild type cells, suggesting that this decrease of AHR could be protected by HSP90
(Figure 2A). qPCR data showed that 4 h HBSS treatment significantly increased the amount of the ahr
message in wild type HeLa cells (Figure 2C). Co-treatment of a transcription inhibitor actinomycin
D with HBSS in wild type HeLa cells abolished the increase of AHR protein levels caused by HBSS
(Figure 2D). Collectively, these data supported that although nutrient deprivation caused degradation
of AHR via autophagy initially, it increased the synthesis of the AHR protein, which led to the steady
rise of the AHR protein levels up to four hours of nutrient deprivation.
2.3. Down-Regulation of p23 in HeLa Cells Exhibits Higher Autophagic Flux
Next, we examined whether knockdown of p23 in HeLa cells stimulates autophagy, which in turn
accelerates the degradation of the AHR protein. It is well accepted that LC3B-II plays a key role in
macroautophagy [28]. Its turnover can be used as a marker for autophagic flux, which reflects the
frequency of events from autophagosome formation to substrate degradation during macroautophagy.
In other words, the amount of LC3B-II in the autophagosomes and lysosomes is directly proportional
to the autophagy activity, which is referred to as the autophagic flux. We measured the LC3B-II
protein levels and observed that the LC3B-II band was more intense in p23 knockdown HeLa cells
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than in wild type cells (Figure 3A, “WT, 0 h” versus “p23KD, 0 h”). Since CQ inhibits the LC3B-II
degradation by acidic proteases in the lysosomes, the LC3B-II content can be more easily detected in
the presence of CQ. The autophagic flux, which was determined by the slope of LCB-II levels over time
with CQ treatment, was also higher in p23 knockdown than in wild type cells (Figure 3A), suggesting
that down-regulation of p23 in HeLa cells sensitized macroautophagy. Next, we performed a PCR
array to test whether knockdown of p23 would change the expression of autophagy-related genes.
The expression of 84 autophagy-related genes (Table S1) was measured using the Qiagen RT2 Profiler
PCR array kit. However, the gene expression related to autophagy was not significantly different
between wild type and p23 knockdown HeLa cells (Figure 3B), suggesting that the down-regulation of




Figure 2. Short-term nutrient deprivation triggers the degradation of AHR in HeLa cells when either 
p23 or HSP90 is down-regulated. (A) Zero to four hours’ treatment of HBSS (nutrient deprivation) in 
wild type (WT), p23 stable knockdown (p23KD), and HSP90 stable knockdown (HSP90KD) HeLa 
cells. Fifteen minutes of HBSS treatment decreased AHR protein levels in p23KD and HSP90 HeLa 
cells but not in WT HeLa cells. Longer nutrient deprivation of up to 4 h increased AHR protein levels 
in all three cell lines. The graph represents replicate data of means ± SD (upper error bars shown), n = 
3 for all, except n = 4 for HSP90KD data from 0 to 1 h. Zero timepoints in each cell line were arbitrarily 
set as one for comparison. Data were analyzed by unpaired two-tailed t-test for comparisons between 
zero and 15 min timepoints in each individual cell line (significant data points marked with # symbol). 
Data were analyzed by two-way ANOVA (mixed-model) analysis corrected with the Dunnett test for 
multiple comparisons to determine the statistical significance between WT and p23KD or WT and 
HSP90 KD at each time point (significant data points marked with * symbol). WT HeLa data were set 
as a control group at each timepoint for comparison. The images above represent the replicate data. 
Note that the timepoints are intentionally presented not in chronological order to preserve the 
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Figure 2. Short-term nutrient deprivation triggers the degradation of AHR in HeLa cells when either
p23 or HSP90 is down-regulated. (A) Zero to four hours’ treatment of HBSS (nutrient deprivation) in
wild type (WT), p23 stable knockdown (p23KD), and HSP90 stable knockdown (HSP90KD) HeLa cells.
Fifteen minutes of HBSS treatment decreased AHR protein levels in p23KD and HSP90 HeLa cells but
not in WT HeLa cells. Longer nutrient deprivation of up to 4 h increased AHR protein levels in all
three cell lines. The graph represents replicate data of means ± SD (upper error bars shown), n = 3 for
all, except n = 4 for HSP90KD data from 0 to 1 h. Zero timepoints in each cell line were arbitrarily set
as one for comparison. Data were analyzed by unpaired two-tailed t-test for comparisons between
zero and 15 min timepoints in each individual cell line (significant data points marked with # symbol).
Data were analyzed by two-way ANOVA (mixed-model) analysis corrected with the Dunnett test for
multiple comparisons to determine the statistical significance between WT and p23KD or WT and
HSP90 KD at each time point (significant data points marked with * symbol). WT HeLa data were
set as a control group at each timepoint for comparison. The images abov represent the replicate
data. Note that the timepoints ar intentionally presented not in chronological order to preserve the
integrity of the original immunoblots. (B) A 40 µM amount of CQ pre-treatment for 6 h block d the
AHR decr ase in p23KD HeLa cells treated with HBSS f r 0–1 h. Zero ime points in e ch con ition
were arbitrarily set as one for comparison. The graph represents replicate data of means ± SD (upper
error bars shown), n = 3. Data were analyzed by multiple t-tests corrected with the Holm-Sidak method
for multiple comparisons to determine the statistical significance. The images above represent the
replicate data. (C) A 4 h HBSS treatment significantly increased the ahr message levels in WT HeLa
cells. The graph represents replicate data of means ± SD, n = 3 of one experiment. This experiment
was repeated once with similar results. Data were analyzed by unpaired t-test to determine statistical
significance. (D) Treatment of 5 µg/mL of actinomycin D (ActD) for 4 h abolished the increase of
AHR protein levels induced by HBSS (nutrient deprivation) in WT HeLa cells. The graph represents
replicate data of means ± SD, n = 3 of one experiment. This experiment was repeated once with similar
results. Data were analyzed by one-way ANOVA with Tukey’s multiple comparisons test to determine
statistical significance. For A to D, each Western lane contained 30 µg of whole-cell lysate. The intensity
of all Western bands was normalized by total protein stain.
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t-tests corrected with the Holm-Sidak method for multiple comparisons to determine the statistical 
significance. The above images are representative of the replicate data. Note that the hour under WT 
is intentionally presented as “6 h, 0 h, 12 h, 24 h” to preserve the integrity of the original immunoblot. 
Each Western lane contained 30 μg of whole-cell lysate. The intensity of Western bands was 
normalized by the total protein stain. (B) Qiagen RT2 Profiler PCR array analysis of 84 autophagy-
related gene expression showing that knockdown of p23 did not alter the autophagy-related gene 
transcription when compared to wild type (WT). The scatter plot compares WT HeLa (x-axis) to p23 
knockdown (p23KD) HeLa (y-axis) with a fold regulation setting as 2. 
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HeLa cells—this type of degradation has been described as selective (macro)autophagy. The 
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Figure 3. Down-regulation of p23 in HeLa cells exhibits ig er autophagic flux. (A) Western blot
analysis showing that p23 stable knockdown (p23K ) ce ls have higher basal LC3B-II protein
levels as well as higher autophagic flux than wild ty ) eLa cells in the pres nce of 40 µM CQ.
The graph in A represents replicate data of means ± S ( er error bars shown), n = 3 of one
experiment. This experiment was repeated once with similar results. Data were analyzed by multiple
t-tests corrected with the Holm-Sidak method for multiple comparisons to determine the statistical
significance. The above images are representative of the replicate data. Note that the hour under WT is
intentionally presented as “6 h, 0 h, 12 h, 24 h” to preserve the integrity of the original immunoblot.
Each Western lane contained 30 µg of whole-cell lysate. The intensity of Western bands was normalized
by the total protein stain. (B) Qiagen RT2 Profiler PCR array analysis of 84 autophagy-related gene
expression showing that knockdown of p23 did not alter the autophagy-related gene transcription
when compared to wild type (WT). The scatter plot compares WT HeLa (x-axis) to p23 knockdown
(p23KD) HeLa (y-axis) with a fold regulation setting as 2.
2.4. AHR Undergoes Selective Autophagy in p23 Knockdown and Wild Type HeLa Cells
Thus far, our data suggested possibly an LC3B-II-dep ndent lysosomal degradation of AHR in
HeLa c lls—this type f de radatio has been described as selective (macro) ut phagy. The selectivity
of autophagy is mainly conveyed by the specific binding of cargo proteins to cargo receptors (e.g., p62)
and the binding of LC3B-II to the cargo protein–cargo receptor complex [29]. We first examined the
role of LC3B in the degradation of AHR in HeLa cells. Stable knockdown of LC3B gene (MAP1LC3B) in
HeLa cells to 12.5% of the wild type LCB-I content showed an increase of the AHR protein levels when
compared to the wild type HeLa cells (Figure 4A, left graph). In addition, knockdown of LC3B led to
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less LC3B-II formed from LC3B-I lipidation and suppressed the CQ effect on AHR, consistent with
our suspicion that CQ might block the LC3B-mediated degradation of the AHR protein (Figure 4A,B,
right graphs). Next, we transiently down-regulated 40% of the LC3B-I content in p23 knockdown
HeLa cells and observed a higher increase of AHR when compared to the LC3B knockdown HeLa cells
(Figure 4A,B, left graphs). The response of AHR to CQ treatment was also significantly suppressed by
the LC3B knockdown (Figure 4B, right graph). Next, we examined whether AHR physically interacts
with LC3B-II, leading to selective autophagy of the AHR protein. We observed that LC3B-II interacted
with AHR in our coimmunoprecipitation experiment and this interaction can be significantly enhanced
by CQ in both wild type and p23 knockdown HeLa cells (Figure 4C). There was also a significant
amount of p62 co-immunoprecipitated with AHR (Figure 4D).
Proximity ligation assay was performed to confirm whether AHR would physically interact with
LC3B and p62 in HeLa cells in situ. We observed that AHR interacted with LC3B (Figure 5A) and p62
(Figure 5B) in both wild type and p23 knockdown HeLa cells, whereas negative control groups without
the addition of antibodies against the interaction partners did not show signals. There were more
AHR–LC3B and AHR–p62 interactions in p23 knockdown than in wild type HeLa cells (Figure 5A,B).
We expected that the signal of the LC3B-AHR interaction should be enhanced in the presence of
CQ since LC3B-II can be accumulated when acidic proteases in the lysosomes are inhibited by CQ.
Indeed, treatment of CQ enhanced the AHR–LC3B interaction significantly in p23 knockdown HeLa
cells but not in WT HeLa cells (Figure 5A). Macroautophagy (or autophagy) can selectively degrade
K63-ubiquitinated target proteins [30]. Given that we observed an interaction between AHR and p62,
which is a known ubiquitin-binding cargo receptor, we examined the ubiquitination status of AHR in
wild type and p23 knockdown HeLa cells. We observed that AHR was K63-ubiquitinated in both cell
lines without exogenous ligand treatment and significantly more K63-ubiquitination was detected in
p23 knockdown HeLa cells (Figure 6A). Both cell lines showed minimal levels of K48-ubiquitinated
AHR protein levels (Figure 6B, “KD NT” and “NT” lanes of image). Co-treatment of an AHR ligand
3MC in the presence of a proteasome inhibitor MG132 showed a more intense K48-ubiquitinated
AHR protein (Figure 6B), which exhibited a pattern that was different from the K63-ubiquitination of
AHR as shown in Figure 6A. Collectively, these data supported that the basal AHR protein undergoes
K63-ubiquitination (but not K48-ubiquitination) in HeLa cells and this K63-ubiquitination is more
apparent when p23 is down-regulated. AHR undergoes p62/LC3-mediated selective autophagy
via K63-ubiquitination in the absence of ligand treatment. Down-regulation of p23 promotes this
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This experiment was  repeated once with  similar  results. Data of  the  left graph were analyzed by 
multiple  t‐tests  corrected  with  the  Holm‐Sidak method  for multiple  comparisons  to  determine 
statistical  significance whereas data of  the  right graph were  analyzed by one‐way ANOVA with 
Sidak’s  multiple  comparisons  test  to  determine  statistical  significance.  (C)  LC3B‐II  was  co‐
Figure 4. AHR interacts with LC3B-II and p62 in p23 stable knockdown (p23KD) and wild type (WT) HeLa
cells. (A) Stable knockdown of LC3B in HeLa cells increased AHR protein levels and reduced the extent of
the CQ-mediated increase of AHR. The images above show LC3B-I, LC3B-II, and AHR protein levels in WT
and LC3B stable knockdown (KD) HeLa cells with or without treatment of 40 µM CQ for 6 h of triplicate
samples. The graphs represent replicate data of means ± SD of one experiment, n = 3. WT (left graph) and
NT (right graph) were arbitrarily set as 1 for data normalization. This experiment was repeated once with
similar results. Data of th left graph ere an lyzed by mult ple t-tests corrected with the Holm-Sidak
method for multiple com arison to det rmine s atistical signific nce w ereas data of the right graph were
analyze by one-w y ANOVA with Sidak’s multiple comparisons test to determine statistic l significance.
(B) Transient knockdown of LC3B in p23 stable knockdown (p23KD) HeLa cells showed a higher increase of
AHR protein levels when compared to that in WT HeLa cells (see A) and reduced the extent of CQ-mediated
increase of AHR. The graphs represent replicate data of means ± SD of one experiment, n = 3. p23KD (left
graph), and no addition as no treatment (NT, right graph) were arbitrarily set as 1 for data normalization.
This experiment was repeated once with similar results. Data of the left graph were analyzed by multiple
t-tests corrected with the Holm-Sidak method for multiple comparisons to determine statistical significance
whereas data of the right graph were analyzed by one-way ANOVA with Sidak’s multiple comparisons test
to determine statistical signific nce. (C) LC3B-II was co-immunoprecipitated by AHR polyclonal antibody
SA210 in both cell lines after treatment of 40 µM CQ for 6 h. Data were presented from three independent
experiments as means ± SD, n = 3. WT HeLa NT group was arbitrarily set as one for comparison (no
error bar). Data were analyzed by multiple t-tests corrected with the Holm-Sidak method for multiple
comparisons to determine statistical significance. The images below are representative of the replicate data.
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(D) p62 was co-immunoprecipitated by AHR monoclonal antibody A-3x after treatment of 40 µM
CQ for 6 h in WT HeLa cells. This experiment was repeated once with similar results. For A-B, each
Western lane contained 30 µg of whole-cell lysate or the whole immunoprecipitation content from 1 to
2 mg of whole-cell lysate starting material (C and D). Data were normalized by total protein stain.
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an AHR ligand 3MC in the presence of a proteasome inhibitor MG132 showed a more intense K48-
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Figure 5. Proximity ligation assay results showing that AHR interacts with LC3B and p62 in wild type 
(WT) and p23 stable knockdown (p23KD) HeLa cells. (A) More AHR–LC3B interaction was detected 
in p23KD than in WT HeLa cells (NT images) and treatment of 40 μM CQ for 6 h increased the 
interaction (CQ versus NT images). (B) p23KD cells showed more AHR–p62 interaction than in WT 
HeLa cells (NT images). The graphs represent replicate data of means ± SD of one experiment, n=3. 
This experiment was repeated twice with similar results. Image J software was used to measure signal 
dots (red channel) and cell numbers (nucleus numbers in the blue channel) in each of the whole 
images captured (signals and nucleus on the edges were excluded). Statistical significance was 
determined by two-way ANOVA with Tukey’s multiple comparisons test (A) and unpaired t-test (B). 
The images are representative of the replicate data with a scale bar at the right bottom of each image. 
Int. J. ol. Sci. 2020, 21, x F R PEER REVIE  11 of 22 
cell lines ithout exogenous ligand treat ent and significantly ore 63-ubiquitination as 
detected in p23 knockdo n eLa cells (Figure 6 ). Both cell lines sho ed ini al levels of 48-
ubiquitinated  protein levels (Figure 6B, “  T” and “ T” lanes of i age). o-treat ent of 
an  ligand 3  in the presence of a proteaso e inhibitor 132 sho ed a ore intense 48-
ubiquitinated  protein (Figure 6B), hich exhibited a pattern that as different fro  the 63-
ubiquitination of  as sho n in Figure 6 . ollectively, these ata suppo ted that the basal  
protein undergoes 63-ubiquitination (but not 48-ubiquitination) in eLa cells and this 63-
ubiquitination is ore apparent en p23 is do n-regulated.  underg es p62/L 3- ediated 
selec
Figure 5. Proxi ity ligation assay results sho ing that R interacts ith L 3B and p62 in ild type 
( T) and p23 stable knockdo n (p23 ) eLa cells. ( ) ore R–L 3B interaction as detected 
in p23  than in T eLa cells ( T i ages) and treat ent of 40 μ   for 6 h increased the 
interaction (  versus T i ages). (B) p23  cells sho ed ore R–p62 interaction than in T 
eLa cells ( T i ages). The graphs represent replicate data of eans ± S  of one experi ent, n=3. 
This experi ent as repeated t ice ith si ilar results. I age J soft are as used to easure signal 
dots (red channel) and cell nu bers (nucleus nu bers in the blue channel) in each of the hole 
i ages captured (signals and nucleus on the edges ere excluded). Statistical significance as 
deter ined by t o- ay  ith Tukey’s ultiple co parisons test ( ) and unpaired t-test (B). 
The i ages are representative of the replicate data ith a scale bar at the right botto  of each i age. 
Figure 5. Proximity ligation assay results showing that AHR interacts with LC3B and p62 in wild type
(WT) and p23 stable knockdown (p23KD) HeLa cells. (A) More AHR–LC3B interaction was detected in
p23KD than in WT HeLa cells (NT images) and treatment of 40 µM CQ for 6 h increased the interaction
(CQ versus NT images). (B) p23KD cells showed more AHR–p62 interaction than in WT HeLa cells (NT
images). The graphs represent replicate data of means ± SD of one experiment, n=3. This experiment was
repeated twice with similar results. Image J software was used to measure signal dots (red channel) and
cell numbers (nucleus numbers in the blue channel) in each of the whole images captured (signals and
nucleus on the edges were excluded). Statistical significance was determined by two-way ANOVA with
Tukey’s multiple comparisons test (A) and unpaired t-test (B). The images are representative of the replicate
data with a scale bar at the right bottom of each image. NC, negative control (cells incubated without
antibodies against interaction partners); NT, no addition as no treatment; CQ, chloroquine in water.
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2.5. AHR is Degraded Via Autophagy in Human Lung, Liver, and Breast Cancer Cell Lines
Next, we examined whether the p62/LC3-mediated autophagy of AHR in HeLa cells can be
observed in other cell types. We observed that the AHR protein levels were significantly increased to
about 1.5- to 1.7-fold in the presence of 40 µM CQ for six hours in a variety of cancer cell types—namely
liver cancer cell line Hep3B, lung cancer cell line A549, and two breast cancer cell lines T-47D and
MDA-MB-468. These results showed that similar to HeLa cells, AHR in these cells is likely degraded
via autophagy in the absence of ligand treatment (Figure 7A). Results from proximity ligation assay
confirmed that AHR interacted with LC3B in the presence or absence of CQ (Figure 7B). In addition,
the interaction between AHR and p62 was detected in all four cell types (Figure 7C).





Figure 7. AHR is degraded via autophagy in human lung, liver, and breast cancer cell lines. (A) 
Treatment of 40 μM CQ dissolved in water for 6 h increased AHR protein levels in A549, Hep3B, T-
47D, and MDA-MB-468 cells (means ± SD; n = 3 of one experiment, except for n = 5 for Hep3B). This 
experiment was repeated once with similar results. Each Western lane contained 30 μg of whole-cell 
lysate. Data are normalized by the total protein stain. NT, no addition as no treatment. An unpaired 
t-test was used to determine statistical significance. The images below are representative of the 
replicate data. Proximity ligation assay results showing that AHR interacted with (B) LC3B and (C) 
p62 in all four cell lines. All images are representative of the replicate data of three independent 
experiments. Each image contains a scale bar at the right bottom. NC, negative control (cells incubated 
without primary antibodies against interaction partners); NT, no addition as no treatment; CQ, 
chloroquine in water. 
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Figure 7. AHR is degraded via autophagy in human lung, liver, and breast cancer cell lines.
(A) Treatment of 40 µM CQ dissolved in water for 6 h increased AHR protein levels in A549, Hep3B,
T-47D, and MDA-MB-468 cells (means ± SD; n = 3 of one experiment, except for n = 5 for Hep3B). This
experiment was repeated once with similar results. Each Western lane contained 30 µg of whole-cell
lysate. Data are normalized by the total protein stain. NT, no addition as no treatment. An unpaired
t-test was used to determine statistical significance. The images below are representative of the replicate
data. Proximity ligation assay results showing that AHR interacted with (B) LC3B and (C) p62 in all
four cell lines. All images are representative of t e replicate data of three in ependent experiments.
Each image contains a scale bar t the right bottom. NC, negative control (cells incubate without
primary a tibodies against interaction partners); NT, no addition as o treatme t; CQ, chloroquine
in water.
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2.6. Chaperone-Mediated Autophagy Is Unlikely Involved in the Degradation of AHR in HeLa Cells
Next, we explored whether another selective autophagic pathway, namely chaperone-mediated
autophagy, could degrade AHR in HeLa cells. This type of autophagy requires interaction with the
lysosomal membrane-bound protein LAMP2A for the internalization of cargo protein into lysosomes
for degradation. When HeLa cells were treated with 100 µM 6-AN, a chaperone-mediated autophagy
activator, for 24 h, the AHR levels were not significantly altered (Figure 8). However, the LAMP2
immunoblot signal, which was detected using an antibody that recognizes both LAMP2A and
LAMP2B, was significantly reduced after the 6-AN treatment. Collectively, we were not able to show
any involvement of chaperone-mediated autophagy in the degradation of AHR in HeLa cells.
Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 14 of 22 
2.6. Chaperone-Mediated Autophagy Is Unlikely Involved in the Degradation of AHR in HeLa Cells 
Next, we explored whether another s lective autophagic pathwa , namely chaperone-mediated 
autophagy, could d grade AHR in HeLa cells. This type of autophagy requires interac ion with the 
lysosomal membran -bound protein LAMP2A for the internalization of ca go protein into lysosomes 
for degradation. When HeLa cells were treated with 100 µM 6-AN, a chaperone-mediated 
autophagy ac
Figure 8. Activation of chaperone-mediated autophagy does not degrade AHR in HeLa cells. Wild 
type (WT) HeLa cells were treated with a chaperone-mediated autophagy activator 6-
aminonicotinamide (6-AN, 100 μM) for 24 h. Treatment of 6-AN did not change AHR protein levels 
(bottom left graph) but reduced LAMP2 levels (bottom right graph). Images above are representative 
of triplicate samples in one experiment and this experiment was repeated once with similar results. 
Each Western lane contained 30 μg of whole-cell lysate. Data are normalized by the total protein stain. 
The plots represent means ± SD, n = 3. An unpaired t-test was used to determine statistical 
significance. 
3. Discussion
We used HeLa cells for this study since HeLa cells were one of the human cell lines, we first tried 
that exhibit apparent p23-dependent degradation of AHR [15]. HeLa cells increase the AHR content 
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the acidification of lysosomes and the fusion of autophagosomes with lysosomes [31] whereas 3MA 
inhibits autophagosome formation via inhibition of class III PI3K at the early stages of autophagy 
[32]. The basal AHR protein can be ubiquitinated via K63-linkage and then degraded in LC3B-
dependent autophagy. p62 likely acts as the cargo receptor of AHR to undergo autophagy since we 
can detect the AHR–p62 interaction by co-immunoprecipitation study and proximity ligation assay. 
Similarly, it has been reported that Dvl is degraded via the p62/LC3-mediated autophagy upon Wnt 
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Figure 8. Activation of chaperone-mediated autophagy does not degrade AHR in HeLa cells. Wild type
(WT) HeLa cells were treated with a chaperone-mediated autophagy activator 6-aminonicotinamide
(6-AN, 100 µM) for 24 h. Treatment of 6-AN did not change AHR protein levels (bottom left graph) but
reduced LAMP2 levels (bottom right graph). Images above are representative of triplicate samples
in one experiment and this experiment was repeated once with similar results. Each Western lane
contained 30 µg of whole-cell lysate. Data are normalized by the total protein stain. The plots represent
means ± SD, n = 3. An unpaired t-test was used to determine statistical significance.
3. Di cussio
We used HeLa cells for this study since HeLa cells were one of the human cell lines, we first tried
that exhibit apparent p23-dependent degradation of AHR [15]. HeLa cells increase the AHR content
after the treatment of an autophagy inhibitor such as CQ, Baf A1, or 3MA. CQ and Baf A1 suppress
the acidification of lysosomes and the fusion of autophagosomes with lysosomes [31] whereas 3MA
inhibits autophagosome formation via inhibition of class III PI3K at the early stages of autophagy [32].
The basal AHR protein can be ubiquitinated via K63-linkage and then degraded in LC3B-dependent
autophagy. p62 likely acts as the cargo receptor of AHR to undergo autophagy since we can detect
the AHR–p62 interaction by co-immunoprecipitation study and proximity ligation assay. Similarly,
it has been reported that Dvl is degraded via the p62/LC3-mediated autophagy upon Wnt ligand
activation [33]. In addition, TH9 cell transcription factor is selectively degraded via the p62/LC3
pathway in an Atg5-dependent manner [34]. Selectivity is largely conferred by the ubiquitination
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architectures of the client proteins and the preference of the cargo receptor to certain ubiquitin chains
and cargoes. The chain formation including chain length, mixed, or branched chains may attach
more information for the ubiquitin code. Post-translational modification of both the adaptors and the
ubiquitin chains also add more layers of regulation [21,35,36]. Characterization of the ubiquitination
machinery and the nature of the AHR–p62 interactions would provide a better picture of how AHR
undergoes the LC3B-mediated autophagy.
As a co-chaperone of HSP90, p23 has been reported to stabilize HSP90 confirmation and assist
AHR activation [37]. The expression of p23 is ubiquitous; however, there is limited, if any, information
regarding the regulation of p23 gene expression. Additionally, there is no evidence showing that the p23
levels can be altered in the presence of an AHR ligand. Although p23 stabilizes AHR from degradation
in cell lines [15,16], there is limited information on how p23 maintains the AHR protein levels in the
absence of ligand treatment. In this study, the increase of the AHR protein levels in HeLa cells by
CQ is higher when p23 is down-regulated, consistent with the notion that CQ inhibits autophagy,
which is responsible for the p23-dependent AHR degradation. Proteins with a glutamine-rich region
(such as AHR) are known to be more prone to aggregation, and these proteins can be degraded by
autophagy [38]. Since p62/LC3 is involved in autophagic degradation of misfolded proteins [39],
reduction of the p23 content in HeLa cells may allow AHR to be more prone to aggregation and
become accessible for ubiquitination. This hypothesis is supported by our findings that the response
of AHR to autophagy inhibition, activation, and LC3B knockdown are more pronounced in HeLa
cells when p23 is down-regulated. Moreover, the interaction between AHR and p62 (or LC3B) is more
apparent in p23 knockdown HeLa cells. The autophagy-related gene expression, however, did not
show any significant difference between wild type and p23 knockdown HeLa cells. Although we are
not aware of any report showing the correlation between p23 and autophagy activity, the basal LC3B-II
levels and the autophagic flux are unambiguously higher when p23 is down-regulated in HeLa cells.
Collectively, we concluded that the down-regulation of p23 promotes autophagy to selectively degrade
AHR without altering the expression of any autophagy-related gene. Importantly, the down-regulation
of p23 in HeLa cells causes more K63-ubiquitination of AHR in the absence of ligand treatment,
revealing that reduction of the cellular p23 content to about 50% in HeLa cells is sufficient to promote
the K63-ubiquitination of AHR, leading to the p62/LC3B-mediated selective autophagy.
Interestingly, it has been reported that HIF-1α—another member of the AHR PAS protein
family—can be K63-ubiquitinated, and this ubiquitination leads to chaperone-mediated autophagy
of HIF-1α during serum deprivation [40]. HIF-1α is constantly degraded by 26S proteasome under
normoxic conditions. In the absence of serum, the KFERQ-like motif of HIF-1α interacts with HSC70;
K63-ubiquitination of HIF-1α apparently causes the interaction between HIF-1α and the lysosomal
membrane-bound LAMP-2A—a necessity for internalization of HIF-1α into lysosomes for degradation.
We examined the possible role of chaperone-mediated autophagy in AHR protein degradation in HeLa
cells. However, activation of chaperone-mediated autophagy by 6-AN did not alter the AHR content in
HeLa cells. In addition, starvation of HeLa cells for four hours caused an increase of the AHR content
whereas prolonged starvation in rodents is known to cause chaperone-mediated autophagy [41].
Collectively, chaperone-mediated autophagy is unlikely to be involved in the degradation of AHR
in HeLa cells. Reduction of the LAMP2 levels in HeLa cells upon 6-AN treatment is surprising since
activation of chaperone-mediated autophagy often increases the LAMP2A levels at the lysosomal
membrane [42]. Realizing that the LAMP2 antibody we used to detect LAMP2A cannot differentiate
LAMP2A from LAMP2B, we cannot rule out the possibility that LAMP2B may be suppressed by 6-AN
treatment in HeLa cells.
This p62/LC3B-mediated AHR degradation is analogous to the cargo-induced model of selective
autophagy, which involves the formation of the K63-ubiquitinated client proteins that are recognized by
the cargo receptors [43]. Although both cargo-induced and starvation-induced autophagy involve the
formation of autophagosome and fusion of the autophagosome with the lysosome, the signaling cascade
and the involvement of autophagy-related (Atg) proteins are not exactly identical [21]. It is evidence that
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AHR can be degraded when autophagy is induced by nutrient deprivation or treatment of metformin.
However, autophagy induction via nutrient deprivation quickly increases the amount of AHR. During
that time, HSP90 protects the AHR protein from degradation, consistently with the literature that
inhibition of HSP90 leads to client protein degradation through autophagy [44–46] and inhibition of
HSP90 by geldanamycin results in the proteasomal degradation of AHR [47]. Down-regulation of
HSP90 in HeLa cells exhibits more AHR degradation upon early nutrient deprivation; subsequently,
AHR levels are steadily increased due to the up-regulation of the AHR gene transcription. We previously
discovered that the protective role of p23 on the AHR levels does not require HSP90, since stable
knockdown of HSP90 to 55% of its wild type content in HeLa cells does not alter the AHR levels
and p23 mutants with modest HSP90 binding affinity can still effectively restore the AHR levels [23].
Although we observed that degradation of AHR occurs after 15-min treatment of HBSS in HSP90
knockdown HeLa cells, this reduction is unique to nutrient deprivation and is temporary, probably
involves the general HSP90 protection of protein folding under stress; it is rather different from the
previous observation that the long-term, steady-state AHR levels are not affected by the reduction
of HSP90. Studying the underlying mechanisms of how HeLa cells trigger the synthesis of AHR in
response to autophagy induction by nutrient deprivation might reveal a potential role of AHR in the
autophagy-related diseases, such as neurodegenerative diseases and tumorigenesis.
4. Materials and Methods
4.1. Reagents
3MA, bafilomycin A1, and metformin were purchased from Cayman Chemical (Ann Arbor, MI, USA).
Chloroquine, rabbit IgG, Duolink proximity ligation assay kit, and anti-LC3B rabbit IgG were purchased
from Sigma (St. Louis, MO, USA). Cycloheximide, anti-AHR monoclonal mouse IgG (A-3x, used for
proximity ligation assay and co-immunoprecipitation for p62 due to less interference in the region of
p62 on Western analysis), anti-LAMP2 (H4B4), and anti-HSP90 goat IgG (N-17) were purchased from
Santa Cruz Biotechnology (Dallas, TX, USA). HBSS was purchased from Gibco (Grand Island, NY, USA).
Puromycin was purchased from Goldbio (St Louis, MO, USA). FBS was purchased from Gemini Bio
(West Sacramento, CA, USA). HyClone DMEM, protein G Dynabeads, anti-p23 mouse IgG (JJ3), and all
cell culture reagents (if not specified) were purchased from Thermo Fisher Scientific (Rockford, IL, USA).
Direct-zol RNA kit was purchased from Zymo Research (Irvine, CA, USA). MMLV high-performance
reverse transcriptase was purchased from Epicentre (Madison, WI, USA). qPCR SYBR Green supermix
was purchased from Bio-Rad (Hercules, CA, USA). Zymopure maxiprep kit was purchased from Zymo
Research (Irvine, CA, USA). RT2 Profiler PCR array plates were purchased from Qiagen (Germantown,
MD, USA). K48- and K63-TUBE were purchased from LifeSensors (Malvern, PA, USA). p23 shRNA,
HSP90 shRNA, and LC3B shRNA were purchased from Dharmacon (Lafayette, CO, USA). Anti-AHR
rabbit IgG (SA210) and anti-p62 rabbit IgG were purchased from Enzo Life Sciences (Farmingdale,
NY, USA). Anti-β-actin mouse IgG was purchased from Ambion (Austin, TX, USA). All secondary IgG
and streptavidin conjugated with IRDye 800CW or 680 were purchased from LI-COR Bioscience (Lincoln,
NE, USA). The pCMV-VSV-G (8454) and pCMV-dR8.2 dvpr packaging plasmid (8455) were purchased
from Addgene (Watertown, MA, USA).
4.2. Cell Culture
All cell lines were authenticated by ATCC and were maintained at 37 ◦C and 5% CO2. HeLa,
A549, and T-47D cells were cultured in DMEM supplemented with 10% fetal bovine serum, 2 mM
GlutaMAX-I, 10 U/mL of penicillin, and 10 mg/mL of streptomycin. Hep3B and MDA-MB-468 cells
were grown in Advanced MEM with 5% fetal bovine serum, 2 mM GlutaMAX-I, 10 U/mL of penicillin,
and 10 mg/mL of streptomycin. For nutrient deprivation study, cells were rinsed with HBSS twice and
then grown in HBSS for the designated period.
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4.3. Generation of HSP90, p23, and LC3B Stable Knockdown Cells
Protocols for the generation of the shRNA-containing lentiviruses and lentiviral infection were
previously described [15]. p23 knockdown HeLa cells were generated using p23-specific shRNA
(#1475); HSP90 knockdown HeLa cells were generated using the HSP90α-specific shRNA (#6, 8563),
and LC3B knockdown HeLa cells were generated using the MAP1LC3B-specific shRNA #153286
and #151769. In essence, AD-293 cells (about 7 × 105 cells) were plated in 5 mL of medium without
antibiotics in a 25 cm2 flask. After incubation at 37 ◦C and 5% CO2 overnight, cells reached 50%–80%
confluence. Fresh medium without antibiotics was exchanged. Cells were transfected using EndoFectin
reagent (2:1 DNA ratio) with the plasmids cocktail as follows: 2.5 µg of specific shRNA plasmid,
1.875 µg of the pCMV-dR8.2 dvpr packaging plasmid, and 0.625 µg of the VSV-G envelope plasmid.
Fresh complete medium was exchanged 15 h later. Medium which contained the virus was collected
after 24 h and stored at 4 ◦C. Another 5 mL of fresh complete medium was added to cells and was
collected 24 h afterwards. The combined medium was centrifuged at 400 g for 5 min to remove any
AD-293 cells that were inadvertently collected. The resulting supernatant was used for infection.
The infection of HeLa cells was performed by first seeding cells in a 75 cm2 flask to 50%–70% confluence.
Fresh complete medium containing 8 µg/mL of polybrene was exchanged. Supernatant containing
lentiviral particles (0.5–1 mL) was then added. The fresh complete medium was exchanged 24 h after
infection. The selection was started by adding 1.5 µg/mL of puromycin 48–54 h after infection. Western
analysis was performed to determine the target protein levels after 2–3 passages.
4.4. Transient Transfection
Cells were grown in 6-well plates and transfection was initiated when cells were about 90%
confluence. Cells were transfected with 2.5 µg of DNA and 5 µL of EndoFectin reagent. Fresh complete
medium was exchanged 24 h after transfection. Treatment of CQ was started at 48 h post-transfection
and cells were harvested at 54 h post-transfection.
4.5. Whole-Cell Lysate Preparation and Western Analysis
Cell pellets were resuspended using lysis buffer (25 mM HEPES, pH 7.4, 0.4 M KCl, 1 mM
EDTA, 1 mM DTT, 10% glycerol, 1% NP-40, 1 mM PMSF, and 2 µg/mL of leupeptin) of 2.5× volume
of cell pellets. After three cycles of freeze/thaw, lysates were kept on ice for 30 min and were then
centrifuged at 16,000 g for 10 min at 4 ◦C. The supernatants were defined as whole-cell lysates and
were subjected to BCA assay and LI-COR Western analysis. The protocol for Western analysis was
described previously [48] with minor modification. Fifteen percent acrylamide gels were transferred
for 3 h at 4 ◦C. After the wet transfer, total protein staining was performed using LI-COR Total Protein
Stain. Membranes for the examination of LC3B levels for autophagic flux were dried overnight and
wet with PBS before blocking. The transferred nitrocellulose membranes were blocked in PBS with
5% BSA for 1 h. Dilutions for antibodies were as follows: 1:1,000 for p23 (JJ3), p62, LC3B and AHR
(A-3x); 1:2,000 for AHR (SA210); 1:5,000 for β-actin; 1:200 for HSP90 (N-17). If not specified, Western
bands were normalized using total protein stain. Results were obtained and analyzed using an LI-COR
Odyssey CLx imaging system.
4.6. RT-qPCR
RT-qPCR was performed as described previously [23]. In brief, RNA was extracted using
the Direct-zol kit. Reverse transcription was performed from 0.5 to 1 µg of RNA using
Epicentre MMLV reverse transcriptase. Quantitative PCR was performed with: 1 µL of cDNA
from reverse transcription solution, 10 µL of Bio-Rad iTaq SYBR green supermix, and 0.8
pmol sequence-specific primers (AHR primers are OL615, 5’-ACATCACCTACGCCAGTCGC-3’
and OL616, 5’-TCTATGCCGCTTGGAAGGAT-3’ whereas β-actin primers are OL101,
5’-CCACACTGTGCCCATCTAGG-3’ and OL102, 5’-AGGATCTTCATGAGGTAGTCAGTCAG-3’)
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using a Bio-Rad CFX Connect real-time PCR machine with the following protocol: 40 cycles of
90 ◦C for 10 s/60 ◦C for 1 min with fluorescence readings taken at 60 ◦C. The 2 −∆∆Cq method [49]
was used to present the normalized values. For RT2 Profiler PCR Array, reverse transcription was
performed with 0.5 µg of RNA using Epicentre MMLV reverse transcriptase. PCR master mix (1,350 µL
of Bio-Rad iTaq SYBR green supermix, 102 µL of cDNA synthesis solution, and 1,248 µL of RNase-free
water) was prepared and an aliquot of 25 µL was added to each well of the RT2 Profiler PCR Array
plate. A Bio-Rad CFX Connect real-time PCR machine was used with the following protocol: 95 ◦C for
10 min, followed by 40 cycles of 95 ◦C for 15 sec/60 ◦C for 1 min (ramp rate between 95 ◦C to 60 ◦C
step was set as 1 ◦C/sec). Data analysis was performed at Qiagen GeneGlobe Data Analysis Center
(www.qiagen.com/shop/genes-and-pathways/data-analysis-center-overview-page).
4.7. Immunoprecipitation and Co-Immunoprecipitation Experiments
Immunoprecipitation was performed as described previously [23]. In brief, cells were lysed with
the method described under 4.5. Three deubiquitylase inhibitors, namely 1,10-phenanthroline (5 mM),
NEM (10 mM), and PR-619 (50 µM) were added in the lysis buffer for immunoprecipitation experiment
with K48- and K63-TUBE Far-western analysis. One to two milligrams of whole-cell lysates were used
for immunoprecipitation (IP) and co-immunoprecipitation (co-IP) of AHR using anti-AHR antibody
SA210 (1:200 by volume) or anti-AHR antibody A-3x (1:100 by volume for AHR–p62 co-IP) for 30 min
at room temperature. The pre-equilibrated Protein G Dynabeads (1:200 by volume) were then added
to each sample with the assay buffer: 25 mM HEPES, pH 7.4, 0.15 M NaCl, 1 mM EDTA, 1 mM DTT,
10% glycerol, 0.1% Tween-20 for IP (0.05% Tween-20 for co-IP), and 1 mg/mL of BSA. The samples
were incubated with a rotation of 60 rpm overnight at 4 ◦C. The beads were then washed three times
for 5 min each with the assay buffer and then eluted with electrophoresis sample buffer for SDS-PAGE,
followed by LI-COR Western analysis.
4.8. K48- and K63-TUBE and Far-Western Analysis
HeLa cells were seeded and cultured overnight in a 75 cm2 flask. Treat the cells with DMSO
(0.1%), 3MC (1 µM), and/or MG132 (10 µM) for 2 h and then harvested with cold PBS. Cell lysates were
obtained using a lysis buffer (see Section 4.5) with a 4× volume of the cell pellet. Immunoprecipitation
was performed as described under 4.7, followed by Far-western analysis. K48- or K63-TUBE (1:1,000)
were incubated with the nitrocellulose membrane for 1 h at room temperature and then with IRDye-800
conjugated streptavidin (1:10,000) for 2 h at room temperature. The wash step between incubation was
the same as in Western analysis. Results were obtained and analyzed using an LI-COR Odyssey CLx
imaging system.
4.9. Proximity Ligation Assay
Cells were seeded on round microscope glass coverslips placed in wells of a 12-well plate and
grown to about 80% confluence. Cells were then rinsed with PBS twice and incubated with ice-cold
100% methanol for 5 min. After one rinse with PBS, cells were ready for proximity ligation assay using
Duolink in situ kit. In brief, cells were incubated with Duolink blocking solution (40 µL) at 37 ◦C
for 60 min, followed by incubation with the two antibodies (in Duolink antibody diluent) used for
interaction study (40 µL) at 37 ◦C for 60 min using the following dilution: mouse anti-AHR A-3x
(1:100), rabbit anti-p62 (1:100), and rabbit anti-LC3B (1:100). After that, we performed steps involving
Duolink probe incubation, ligation, and amplification according to the manufacturer’s recommendation.
Nucleus staining was performed by adding 1 µg/mL of DAPI in water to cells for a 1 min incubation.
Coverslips were mounted using 6 µL of PBS and were sealed with nail polish. Samples were viewed
using a KEYENCE BZ-X700 fluorescence microscope and results were analyzed by ImageJ software.
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4.10. Statistical Analysis
GraphPad Prism 8 software (La Jolla, CA) was utilized for statistical analysis. Two-tailed unpaired
t-test, multiple t-tests corrected with the Holm-Sidak method for multiple comparisons, and one-way
and two-way (or mixed-model) ANOVA with Sidak, Tukey or Dunnett tests for multiple comparisons
were used to determine statistical significance with *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001,
and ns, not significant (p > 0.05).
5. Conclusions
In summary, we uncovered a mechanism for AHR protein degradation in HeLa cells. We observed
that AHR is K63-ubiquitinated and binding of AHR to p62 and LC3B-II occurs. Inhibition of autophagy
increases AHR protein levels. These observations are more pronounced when p23 is down-regulated
in HeLa cells, suggesting that reduction of the p23 content stimulates autophagy to degrade AHR.
Other than HeLa cells, four other human cell lines also show the autophagy-dependent regulation of
the AHR protein levels and exhibit AHR–LC3B-II and AHR–p62 interactions. Collectively, the AHR
content is controlled by selective autophagy—a novel understanding of how human cells maintain the
AHR protein levels. This mechanism can potentially be manipulated in an effort to control the AHR
levels for clinical applications.
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